Aquestive Therapeutics, Inc. (AQST) Revenue 2017–2025
Aquestive Therapeutics, Inc. (AQST) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$44.5MFY2025 · since FY2017: $66.9M → $44.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $44.5M | -22.6% |
| FY2024 | $57.6M | +13.8% |
| FY2023 | $50.6M | +6.1% |
| FY2022 | $47.7M | -6.2% |
| FY2021 | $50.8M | +10.9% |
| FY2020 | $45.8M | -12.8% |
| FY2019 | $52.6M | -22.0% |
| FY2018 | $67.4M | +0.8% |
| FY2017 | $66.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice